Malaga Cove Capital’s Opko Health OPK Stock Holding History

Malaga Cove Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,175	Closed	-$39K	–	179
2018 Q3	$39K	Hold	11,175	–	–	0.02%	158
2018 Q2	$53K	Hold	11,175	–	–	0.03%	150
2018 Q1	$35K	Buy	+11,175	New	+$45K	0.02%	148
2017 Q4	–	Sell	-11,175	Closed	-$77K	–	149
2017 Q3	$77K	Buy	+11,175	New	+$70.5K	0.04%	130

Other funds holding OPK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Malaga Cove Capital's OPK Position: Q4 2018 in Review

Malaga Cove Capital sold out of Opko Health (OPK) in Q4 2018, closing a stake of 11,175 shares — an estimated $39K sold.

Malaga Cove Capital first reported a position in OPK in Q3 2017 and held it in 4 quarters. The position peaked at $77K in Q3 2017. 202 funds tracked by Wall St. Rank hold OPK as of Q4 2018.

Malaga Cove Capital reported no remaining Opko Health position as of Q4 2018 after selling out during the quarter.
Malaga Cove Capital sold 11,175 Opko Health shares in Q4 2018, an estimated $39K.
Malaga Cove Capital first reported a position in Opko Health in Q3 2017 and held it in 4 quarters.
Malaga Cove Capital's Opko Health position peaked at $77K in Q3 2017.
202 funds tracked by Wall St. Rank held Opko Health as of Q4 2018.

Based on Malaga Cove Capital's 13F filing for Q4 2018, filed 4 Feb 2019.